Advances in the prevention of venous thromboembolic disease.
D004087:Dihydroergotamine / Q000627:therapeutic use; D006025:Glycosaminoglycans / Q000627:therapeutic use; D006801:Humans; D008970:Molecular Weight; D013924:Thrombophlebitis / Q000517:prevention & control*
D006025:Glycosaminoglycans; C013786:A73025; D004087:Dihydroergotamine